In a May 15, 2025, opinion, Judge Dabney Friedrich of the US District Court for the District of Columbia denied drugmakers’ motions for summary judgment against the US Department of Health and Human Services and the Health...more
5/30/2025
/ Department of Health and Human Services (HHS) ,
Drug Pricing ,
HRSA ,
Judicial Authority ,
Manufacturers ,
Medicaid ,
Motion for Judgment ,
Pharmaceutical Industry ,
Pre-approval ,
Prescription Drugs ,
Rebates ,
Regulatory Authority ,
Sanofi ,
Section 340B
In February 2025, the Office of Inspector General (OIG) for the US Department of Health and Human Services issued favorable advisory opinions Advisory Opinion 24-10 and Advisory Opinion 24-12, providing additional guidance on...more
On January 15, 2025, the Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) issued a series of rules relating to the telemedicine prescribing of controlled substances, including a proposed...more
On November 1, 2023, the Cybersecurity and Infrastructure Security Agency (“CISA”) and the Department of Health and Human Services (“HHS”) co-hosted a roundtable discussion on the cybersecurity challenges that the US...more